Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results
Go back to Myriad Genetics Reports Fiscal Fourth-Quarter and Full-Year 2018 Financial Results| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 4.35 -0.28 (6.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.63 | 52 Week High | $45.34 | |||
| Open | $4.63 | 52 Week Low | $15.92 | |||
| Day High | $4.67 | P/E | 1.87 | |||
| Day Low | $4.32 | EPS | $2.33 | |||
| Volume | 548,698 | |||||
